Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer

Prostate

Volumn 72, Issue 11, 2012, Pages 1193-1199

  Barron, Niall ^a   Keenan, Joanne ^a   Gammell, Patrick ^a,d   Martinez, Vanesa G ^a,e   Freeman, Alex ^b   Masters, John R ^c   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d PFIZER INC   (United States)

^e Centre Esther Koplowitz   (Spain)

Author keywords

miR 200; miRNA; relapse

Indexed keywords

MICRORNA 200A;

ARTICLE; BIOCHEMICAL COMPOSITION; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TRANSIENT TRANSFECTION; WOUND HEALING;

CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TRANSFECTION;

EID: 84862863817     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22469     Document Type: Article

References (23)

1. Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV,. Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLOS One 2009; 4: 5279.
2. Cullen BR,. Derivation and function of small interfering RNAs and microRNAs. Virus Res 2004; 102: 3-9.
3. Lee I, Ajay SS, Yook JI, Kim HS, Hong SH, Kim NH, Dhanasekaran SM, Chinnaiyan AM, Athey BD,. New Class of microRNA trargets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res 2009; 19: 1175-1183.
4. Schickel R, Boyerinas B, Park SM, Peter ME,. MicroRNAs: Key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 6: 5959-5974.
5. Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M, Goggins M,. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res 2010; 70 (13): 5226-5237.
6. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N,. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 2010; 101: 241-249.
7. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC,. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2010; 128: 132-143.
8. Uhlmann S, Zhang JD, Schwäger A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S, Sahin O,. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 2010; 29: 4297-4306.
9. Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, Kung HF, Lin MC,. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun 2010; 391: 535-541.
10. Saydam O, Shen Y, Würdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO,. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol 2009; 29: 5923-5940.
11. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
12. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedel V, Ginzinger DG, Getts Rc, Hagg CM,. Optimized high-throughput miRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006; 19: 24.
13. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R,. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006; 169: 1812-1820.
14. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH,. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009; 27: 1712-1721.
15. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW,. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 2010; 71: 538-549.
16. Kogo R, Mimori K, Tanaka F, Komune S, Mori M,. Clinical Significance of miR-146a in Gastric Cancer Cases. Clin Cancer Res 2011; 17 (13): 4277-4284.
17. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG,. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011; 17: 211-215.
18. Nariculam J, Freeman A, Munson P, Bott SJ, Cable N, Brookman-Amissah N, Williamson M, Feneley MR, Masters JR,. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: The expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors. Asian J Androl 2009; 11: 109-118.
19. Bright RK, Vocke CD, Emmert-Buck MR, Durray PH, Solomon D, Fetsch P, Rhim JS, Linehan WM, Topalian SL,. Generation and genetic characterisation of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997; 57: 995-1002.
20. Housseau F, Langer DA, Oberholtzer SD, Moorthy A, Levitsky HI, Pardoll DM, Topalian SL,. Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines. Int J Cancer 2002; 98 (1): 57-62.
21. Housseau F, Bright RK, Simonis T, Nishimura MI, Topalian SL,. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells. J Immunol 1999; 163 (11): 6330-6337.
22. Albini A,. Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 1998; 4: 230-241.
23. Liang CC, Park AY, Guan JL,. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocol 2007; 2: 329-333.